Andrew D. Zelenetz MD, PhD

Andrew D. Zelenetz, MD, Ph.D., is the Medical Director of Quality Informatics at Memorial Sloan Kettering Cancer Center in New York. Prior to that, he had held the positions of Vice-Chair, Medical Informatics from January 2013 to May 2016 and Chief, Lymphoma Service in the Division of Hematology/Oncology at MSKCC from 1994-December 2012. He is also a Professor of Medicine at Weill Cornell Medical College. Dr. Zelenetz was elected Chair-Elect of the Scientific Advisory Board in 2017, assuming the Chair in 2019.

He has helped develop several agents now approved to treat lymphoma — including 131I-tosituomab/tositumomab, bortezomib, and pralatrexate — and through clinical studies, he is evaluating the benefits of novel combinations of agents. Dr. Zelenetz has also published more than 100 papers on lymphoma research in journals such as Blood, Journal of Clinical Oncology, and Clinical Cancer Research.